Effectiviteit COVID-19-injecties

Kans op ziekte door COVID neemt toe naarmate meer C-injecties zijn gezet.

Risk of Coronavirus Disease 2019 (COVID-19) among Those Up-to-Date and Not Up-to-Date on COVID-19 Vaccination | medRxiv

Covid-injectie biedt geen immuniteit bij teveel mutaties.

Effectiveness of the Coronavirus Disease 2019 Bivalent Vaccine | Open Forum Infectious Diseases | Oxford Academic

Preprint; Met Moderna-prikken 25% meer kans op omikron dan zonder prik.

Effectiveness of mRNA-1273 against infection and COVID-19 hospitalization with SARS-CoV-2 Omicron subvariants: BA.1, BA.2, BA.2.12.1, BA.4, and BA.5 | medRxiv

Risico-batenafweging vaccineren jong volwassenen.

COVID-19 Vaccine Boosters for Young Adults: A Risk-Benefit Assessment and Five Ethical Arguments against Mandates at Universities by Kevin Bardosh, Allison Krug, Euzebiusz Jamrozik, Trudo Lemmens, Salmaan Keshavjee, Vinay Prasad, Martin A. Makary, Stefan Baral, Tracy Beth Høeg :: SSRN

Immune imprinting.

SARS-CoV-2 Spike Protein Vaccine-Induced Immune Imprinting Reduces Nucleocapsid Protein Antibody Response in SARS-CoV-2 Infection – PubMed

Betere bescherming door natuurlijke infectie.

Anti-nucleocapsid antibodies following SARS-CoV-2 infection in the blinded phase of the mRNA-1273 Covid-19 vaccine efficacy clinical trial | medRxiv

Negatieve effectiviteit; meer bevattelijk voor infectie.

Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden – ScienceDirect

Vaccinatie heeft geen enkel effect.

Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States – PubMed

Needed number to vaccinate: + 1000

Evaluating the number of unvaccinated people needed to exclude to prevent SARS-CoV-2 transmissions | medRxiv

Trials wijzen niet uit of er levens gered worden door de COVID-19 injecties.

Will covid-19 vaccines save lives? Current trials aren’t designed to tell us | The BMJ